{
  "schema_version": "0.1.0",
  "case_id": "HR-NI010",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "NI010",
    "display_name": "Vincent van Gogh",
    "aliases": [],
    "name_parts": {
      "given": [
        "Vincent"
      ],
      "family": "van Gogh"
    },
    "sex": "male",
    "era": "19th Century",
    "nationality": "Netherlands",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1853-03-30",
          "display": "March 30, 1853",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1853",
              "display": "1853",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Van Gogh Museum."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1890-07-29",
          "display": "July 29, 1890",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1890",
              "display": "1890",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Van Gogh Museum."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-NI010-SYN",
      "ssn": "000-10-3198",
      "date_of_birth": "1990-03-30",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Elise Verhoeven, MD",
      "fictional_consultant": {
        "name": "Jonah Feld, MD",
        "specialty": "Psychiatry"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1853-03-30",
        "display": "March 30, 1853",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1886",
        "display": "1886",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Heavy drinking in Paris, probably absinthe and wine.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1888-10",
        "display": "October 1888",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Paul Gauguin joined him at the Yellow House in Arles.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1888-12-23",
        "display": "December 23, 1888",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "First crisis, with confusion and an injury to his left ear; taken to hospital the next morning.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1889-01-07",
        "display": "January 7, 1889",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Discharged from the hospital in Arles.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1889-02-07",
        "display": "February 7, 1889",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Readmitted with delirium and hallucinations; admitted again on February 27.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1889-05-08",
        "display": "May 8, 1889",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Voluntary admission to Saint-Paul-de-Mausole, Saint-Remy-de-Provence.",
      "claim_ids": [
        "CLM-0006",
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1889-07",
        "display": "July 1889",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Further crises at Saint-Remy began.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1890-05",
        "display": "May 1890",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Moved to Auvers-sur-Oise.",
      "claim_ids": [
        "CLM-0016"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1890-07-29",
        "display": "July 29, 1890",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Auvers-sur-Oise.",
      "claim_ids": [
        "CLM-0017"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Vincent van Gogh was born on March 30, 1853, and decided to become an artist at the age of 27.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster birth year 1853"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "In October 1888 the painter Paul Gauguin joined Van Gogh at the Yellow House in Arles, in the south of France, where Van Gogh hoped to found an artists' community; their discussions about art became more frequent and heated, and the situation deteriorated.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Social context for the crisis. Gauguin appears only in this history; the modern episode names no real person.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "On December 23, 1888, when he was 35, after a heated argument, Van Gogh cut off his left ear in a state of utter confusion. The police found him at home the next morning and took him to hospital. He could later recall nothing of what had happened.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the synthetic first episode of psychosis and for the history of self-injury during confusion. The record states the documented fact once and repeats no further detail.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "could later recall nothing"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In the hospital in Arles he was treated by the assistant physician Dr. Felix Rey. His condition worsened and he spent several days in isolation; he then recovered slowly and went home after about two weeks, on January 7, 1889.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the brief hospital stay in the modern episode and the timing of the index visit soon after discharge.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "discharged January 7, 1889"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0005",
      "statement": "New attacks followed about a month later. He was admitted to the hospital in Arles again on February 7, 1889, with delirium and hallucinations, and again on February 27, 1889, after neighbours petitioned for him to be confined.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date. Recurrence is why the modern episode treats the first episode as the start of a possibly recurrent illness and plans for early warning signs.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "new attacks just a month later"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "the neighbours' petition"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "On May 8, 1889, he had himself admitted voluntarily to the Saint-Paul-de-Mausole psychiatric hospital in Saint-Remy-de-Provence, where he stayed for a year. The director, Dr. Peyron, entered his diagnosis in the admissions register; Nolen and colleagues report that Peyron described attacks of epilepsy separated by long intervals.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date. The asylum physician's diagnosis of epilepsy is why the modern workup includes an EEG and brain MRI.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "attacks of epilepsy, separated by long intervals"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In a letter to his brother Theo written at the asylum about May 23, 1889, he wrote that after the shock nothing would have been so agreeable to him as never to wake up again, that this horror of life was already less pronounced and the melancholy less acute, and that other patients, like him, had heard sounds and strange voices during their crises.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His own description of a wish not to wake up, of low mood, and of hearing voices during the crises. It anchors the passive death wish recorded, without intent or plan, in the modern safety assessment. Quoted as the Van Gogh Museum quotes the letter.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "letter to Theo, c. 23 May 1889"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Further crises began in July 1889, while he was painting a quarry, and the following months alternated between crises and recovery; Nolen and colleagues count four episodes at Saint-Remy between July 1889 and April 1890.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date; recorded as history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0009",
      "statement": "He drank heavily in Paris from 1886, probably both absinthe and wine, and later wrote to his brother that he had become almost an alcoholic from overdoing it; in Arles he seems to have cut down.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The anchor for the synthetic alcohol use disorder.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "almost an alcoholic as a result of overdoing it"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "heavy drinking from 1886"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0010",
      "statement": "Nolen and colleagues judged that he had an alcohol use disorder, with dependence shown by failed attempts to cut down in Arles, made worse by malnutrition and poor sleep.",
      "evidence_grade": "R",
      "certainty": "probable",
      "clinical_interpretation": "Retrospective interpretation; supports treating alcohol use from the first visit.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0011",
      "statement": "Nolen and colleagues concluded that he probably had a bipolar mood disorder, more likely bipolar II than bipolar I, with recurrent depressive episodes, some of them psychotic, and probably hypomanic symptoms. The Van Gogh Museum states that no all-embracing diagnosis has been found.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective and disputed; one reason the modern diagnosis is provisional with a bipolar disorder in the differential.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "context",
          "locator": "an all-embracing diagnosis is yet to be found"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0012",
      "statement": "Nolen and colleagues also found strong indications of borderline personality traits, present as an underlying vulnerability from young adulthood.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective interpretation from questionnaires completed by art historians; not used as a modern diagnosis.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0013",
      "statement": "Nolen and colleagues proposed that the brief psychosis after the ear incident was a delirium from alcohol withdrawal, because he was forced to stop drinking suddenly when he was admitted to hospital. The writer Martin Bailey questioned part of their reasoning, arguing that they underestimated how much he went on drinking afterwards.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Retrospective and disputed; puts alcohol withdrawal in the modern differential.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "disputes"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0014",
      "statement": "Nolen and colleagues concluded that focal (temporal lobe) epilepsy, which Dr. Rey had suggested in Arles, cannot be excluded as an additional condition, although its probability cannot be judged without an EEG or brain imaging.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective; the reason the modern workup includes an EEG and brain MRI.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0015",
      "statement": "Schizophrenia, Meniere's disease, syphilis, acute intermittent porphyria and thujone poisoning from absinthe have also been proposed; Nolen and colleagues judged schizophrenia and the others unlikely or highly unlikely, because he had no psychotic symptoms between episodes and no negative symptoms.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Retrospective; recorded so that the modern differential is not taken from popular accounts.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0016",
      "statement": "He left Saint-Remy in May 1890 for Auvers-sur-Oise, near Paris, where Dr. Paul Gachet was asked to keep an eye on him. He was exceptionally productive there, but felt lonely and depressed.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the episode; recorded as history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0017",
      "statement": "On July 27, 1890, he shot himself in the chest; he died in Auvers-sur-Oise on July 29, 1890, at the age of 37.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, recorded without detail. It is not used in the modern episode, where suicide-risk care follows the guideline for any person after a first episode of psychosis.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "died July 29 at age 37"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Vincent's Illness and the Healing Power of Art",
      "publisher": "Van Gogh Museum, Amsterdam",
      "url": "https://www.vangoghmuseum.nl/en/art-and-stories/stories/vincents-illness-and-the-healing-power-of-art",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum story quoting his letters; facts and short letter passages used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Why Did Vincent van Gogh Cut off His Ear?",
      "publisher": "Van Gogh Museum, Amsterdam",
      "url": "https://www.vangoghmuseum.nl/en/art-and-stories/vincent-van-gogh-faq/why-did-vincent-van-gogh-cut-off-his-ear",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum FAQ; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "The Life of Vincent van Gogh, 1853-1890",
      "publisher": "Van Gogh Museum, Amsterdam",
      "url": "https://www.vangoghmuseum.nl/en/art-and-stories/vincents-life-1853-1890",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum biography; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "The Last Days of Vincent van Gogh",
      "publisher": "Van Gogh Museum, Amsterdam",
      "url": "https://www.vangoghmuseum.nl/en/art-and-stories/stories/the-last-days-of-vincent-van-gogh",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum story; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Nolen WA, van Meekeren E, Voskuil P, van Tilburg W. New vision on the mental problems of Vincent van Gogh; results from a bottom-up approach using (semi-)structured diagnostic interviews. Int J Bipolar Disord. 2020;8:30 (PMID 33135101; correction 2022)",
      "publisher": "International Journal of Bipolar Disorders (Springer Open)",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7604278/",
      "source_type": "scholarly",
      "published": "2020-11-02",
      "accessed": "2026-11-04",
      "rights_note": "Open-access peer-reviewed article; facts and retrospective interpretations used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Bailey M. Did alcohol withdrawal really cause Van Gogh's mental crises?",
      "publisher": "The Art Newspaper",
      "url": "https://www.theartnewspaper.com/blog/did-alcohol-withdrawal-really-cause-van-gogh-s-mental-crises",
      "source_type": "other",
      "published": "2020-11-13",
      "accessed": "2026-11-04",
      "rights_note": "Specialist art-press blog quoting his letters; used for his drinking and for the critique in CLM-0013."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-01-19",
    "index_age": 35,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Dignified, recovery-oriented primary care for a 35-year-old painter twelve days after discharge from a first psychiatric admission for psychosis with mood features: keeping the diagnosis provisional and stating the differential (bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal or alcohol-induced psychosis, and focal epilepsy), a first-episode workup with brain MRI and EEG, antipsychotic monitoring to the APA and ADA/APA standard (weight at every visit, blood pressure, fasting glucose, A1c and lipids at baseline and 12 weeks, akathisia and movement checks with the AIMS), recognizing and treating akathisia, AUDIT-C, PEth and naltrexone for alcohol use disorder, sleep as treatment and as an early warning sign, coordinated specialty care, and a structured safety assessment with lethal-means counseling and the 988 Suicide & Crisis Lifeline reviewed at every visit, on the APA 2020 schizophrenia guideline, the CANMAT and ISBD bipolar guidelines, and the CMID depression and bipolar monograph.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-01-19",
        "purpose": "Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis, antipsychotic monitoring baseline, first-episode workup, alcohol, sleep, and safety planning"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-02-02",
        "purpose": "Two-week review and psychiatry consultation with the coordinated specialty care team"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-02-16",
        "purpose": "Same-day sick visit for restlessness after an antipsychotic dose increase"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-03-02",
        "purpose": "Six-week review: symptoms, side effects, alcohol, sleep, and test results"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-04-20",
        "purpose": "Three-month review with the 12-week metabolic check"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-06-15",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-07-20",
        "purpose": "Six-month review: diagnosis, relapse prevention, movement check, and alcohol"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "First episode of psychosis with mood features: weeks of very little sleep, intense work and expansive plans, then acute confusion, hallucinations and suspiciousness with self-injury, and low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, brief psychotic or schizophreniform disorder, alcohol withdrawal delirium or alcohol-induced psychotic disorder, and psychosis related to focal epilepsy. Synthetic modern episode linked to his documented first crisis",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F29",
            "display": "Unspecified psychosis not due to a substance or known physiological condition",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0011",
            "CLM-0013",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented first crisis. Unspecified psychosis is coded because the cause is not yet established; the retrospective diagnoses stay in the claims.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "provisional",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Alcohol use disorder, moderate (heavy daily wine and anise spirits before the episode); synthetic modern episode linked to his documented heavy drinking",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F10.20",
            "display": "Alcohol dependence, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented drinking and its retrospective interpretation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Self-injury to the left ear during the acute confusional episode, without suicidal intent; wound healed after surgical care in hospital",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z91.52",
            "display": "Personal history of nonsuicidal self-harm",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented injury; no detail of the injury is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-004",
        "display": "Akathisia from aripiprazole, two weeks after the dose was increased to 15 mg; treated by returning to 10 mg and short-term propranolol; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G25.71",
            "display": "Drug induced akathisia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medication side effect; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-02-16",
        "abatement_date": "2026-03-02"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Aripiprazole 10 mg oral tablet, one tablet by mouth once daily (started in hospital)",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "349545",
            "display": "aripiprazole 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth once daily"
        },
        "start_date": "2026-01-05",
        "end_date": "2026-02-02",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic antipsychotic started by the inpatient team two days before discharge; chosen for its lower metabolic risk.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Aripiprazole 15 mg oral tablet, one tablet by mouth once daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "349490",
            "display": "aripiprazole 15 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth once daily"
        },
        "start_date": "2026-02-02",
        "end_date": "2026-02-16",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic dose increase for residual night-time perceptual disturbances, on the consultant's advice.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Naltrexone 50 mg oral tablet, one tablet by mouth once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1483744",
            "display": "naltrexone hydrochloride 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth once daily"
        },
        "start_date": "2026-02-02",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic medicine for alcohol use disorder; no opioid use, urine drug test negative, and liver tests below three times the upper limit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Thiamine 100 mg oral tablet, one tablet by mouth daily (started in hospital)",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313323",
            "display": "thiamine 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-01-05",
        "end_date": "2026-07-20",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic thiamine for heavy drinking with irregular meals; stopped at six months when drinking was light.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Aripiprazole 10 mg oral tablet, one tablet by mouth once daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "349545",
            "display": "aripiprazole 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth once daily"
        },
        "start_date": "2026-02-16",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic return to the previous dose because of akathisia at 15 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Propranolol 10 mg oral tablet, one tablet by mouth twice daily for akathisia",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "856448",
            "display": "propranolol hydrochloride 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet by mouth twice daily"
        },
        "start_date": "2026-02-16",
        "end_date": "2026-03-02",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic short course of propranolol for akathisia; no asthma, pulse and blood pressure adequate; stopped at six weeks when the akathisia had resolved.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 6.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; raised MCV consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 14.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; raised MCV consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 102,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic blood count; raised MCV consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 172,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; raised MCV consistent with heavy drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 4.1,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 0.94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 108,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FGLU-V1",
        "display": "Fasting glucose [Mass/volume] in Serum or Plasma",
        "label": "Fasting glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 91,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1558-6",
            "display": "Fasting glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic baseline for antipsychotic treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 5.3,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic baseline for antipsychotic treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 184,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic baseline for antipsychotic treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 106,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic baseline for antipsychotic treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 52,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic baseline for antipsychotic treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 130,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting metabolic baseline for antipsychotic treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 58,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic liver tests: AST above ALT with a raised GGT, consistent with alcohol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 44,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic liver tests: AST above ALT with a raised GGT, consistent with alcohol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V1",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 96,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic liver tests: AST above ALT with a raised GGT, consistent with alcohol.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 1.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic thyroid test in the workup of a first episode of psychosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 388,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin B12 level in the workup of a first episode; irregular meals.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V1",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-19",
        "value": 284,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic PEth level consistent with heavy drinking in the weeks before and after the admission.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-01-19",
        "value": 13,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic depression screen; item 9 scored 1 for passive thoughts of not waking up, without intent or plan. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-01-19",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic alcohol screen for the year before the episode; positive.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-02",
        "value": 11,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 1, passive thoughts less frequent.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-02",
        "value": 41,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests four weeks after starting naltrexone; improving.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-02",
        "value": 37,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests four weeks after starting naltrexone; improving.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V3",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-02",
        "value": 68,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests four weeks after starting naltrexone; improving.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V3",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-02",
        "value": 122,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic PEth level; drinking reduced but not stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-02",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-FGLU-V4",
        "display": "Fasting glucose [Mass/volume] in Serum or Plasma",
        "label": "Fasting glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1558-6",
            "display": "Fasting glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 12-week metabolic check on aripiprazole; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 5.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 12-week metabolic check on aripiprazole; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V4",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 191,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 12-week metabolic check on aripiprazole; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V4",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 112,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 12-week metabolic check on aripiprazole; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V4",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 50,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 12-week metabolic check on aripiprazole; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V4",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 142,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic 12-week metabolic check on aripiprazole; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 33,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests on naltrexone; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests on naltrexone; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V4",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 49,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests on naltrexone; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V4",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 46,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic PEth level; light to moderate drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 6.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; MCV back to normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 14.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; MCV back to normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V5",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 95,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; MCV back to normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 214,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; MCV back to normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests, normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 26,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests, normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V5",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 36,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 61
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests, normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PETH-V5",
        "display": "Phosphatidylethanol [Mass/volume] in Blood",
        "label": "Phosphatidylethanol (PEth)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-20",
        "value": 16,
        "unit": "ng/mL",
        "reference_range": {
          "high": 19,
          "text": "Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "74661-0",
            "display": "Phosphatidylethanol [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic PEth level below 20 ng/mL: abstinence or light drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-20",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; remission; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V7",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-15",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V7",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-06-15",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic alcohol screen, below the risk threshold for men.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Brain MRI without contrast",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "816077007",
            "display": "MRI of brain",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-02",
          "end": "2026-02-02"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first-episode imaging, done the morning of the consultation; read as normal (reported at the six-week visit).",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Sleep-deprived routine EEG",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "54550000",
            "display": "Electroencephalogram",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-02",
          "end": "2026-02-02"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic EEG because of the confusion and the question of seizures; read as normal (reported at the six-week visit).",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Advance care planning conversation with a psychiatric advance directive, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-15",
          "end": "2026-06-15"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only his own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-06-15",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose recommended for adults aged 19 to 49 with alcohol use disorder.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-06-15",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination; recommended for all adults aged 19 to 59 with no record of vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-07-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose at least four weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Heavy drinking, probably both absinthe and wine, from his time in Paris",
        "historical_date": {
          "iso": "1886",
          "display": "1886",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "First crisis, with confusion and an injury to his left ear; hospital care in Arles with several days in isolation; went home after about two weeks",
        "historical_date": {
          "iso": "1888-12-23",
          "display": "December 23, 1888",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis, antipsychotic monitoring baseline, first-episode workup, alcohol, sleep, and safety planning",
        "status": "finished",
        "date": "2026-01-19",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review and psychiatry consultation with the coordinated specialty care team",
        "status": "finished",
        "date": "2026-02-02",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Two-week review, seen the same day by psychiatry with the coordinated specialty care team",
          "hpi": {
            "narrative": "Mr. van Gogh returns two weeks after his first visit, four weeks after aripiprazole 10 mg was started in hospital, and is seen by Dr. Feld of the coordinated specialty care team on the same day. He has taken every dose. He has had no confusion and hears nothing by day, but on some nights he still hears his name called as he falls asleep, and on those nights he feels for a while that people in the street are talking about him; by morning he knows this is not so. He sleeps about six hours with breaks. His mood is a little better: he feels less ashamed and has started to sketch, but still cannot paint for long. The passive thoughts that it would be easier not to wake up come less often; he has had no thoughts of suicide or self-harm. He drinks two or three glasses of wine most evenings and no spirits since discharge. He has noticed no restlessness or stiffness. He had his brain MRI and EEG this morning, after a night of shortened sleep as instructed.",
            "elements": [
              {
                "label": "Aripiprazole",
                "value": "10 mg daily for four weeks, every dose taken"
              },
              {
                "label": "Psychotic symptoms",
                "value": "Hears his name called at sleep onset on some nights, with brief suspiciousness; none by day"
              },
              {
                "label": "Mood",
                "value": "Somewhat better; PHQ-9 11; item 9 scored 1, less often"
              },
              {
                "label": "Sleep",
                "value": "About six hours, broken"
              },
              {
                "label": "Alcohol",
                "value": "Two or three glasses of wine most evenings; no spirits"
              },
              {
                "label": "Side effects",
                "value": "None noticed"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; appetite normal"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No restlessness, stiffness, tremor, seizures, or episodes of lost time"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Left ear wound healed; hearing unchanged"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Night-time perceptual disturbances at sleep onset; low mood improving; passive thoughts of not waking up less often; no suicidal intent or plan"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 64.5 kg; waist 86 cm; blood pressure 124/78, pulse 82"
            },
            {
              "system": "Head and ears",
              "finding": "Left ear wound healed, without infection"
            },
            {
              "system": "Neurological",
              "finding": "No akathisia, rigidity, tremor, or abnormal movements; AIMS score 0"
            },
            {
              "system": "Psychiatric",
              "finding": "Quiet and cooperative; affect constricted but brighter; thought process organized; no hallucinations or delusions elicited today; insight good"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "First episode of psychosis with mood features, provisional diagnosis",
              "assessment": "Partial response at four weeks: daytime symptoms gone, with residual perceptual disturbances at sleep onset. Intake results support a primary illness rather than a medical cause: urine drug test negative, HIV and syphilis tests nonreactive, TSH 1.8 mIU/L and vitamin B12 388 pg/mL normal. The diagnosis stays provisional. Dr. Feld agrees with a modest dose increase. Safety reviewed: passive thoughts of not waking up less often, no intent or plan; the safety plan and the 988 Suicide & Crisis Lifeline are in his phone; no firearm access",
              "plan": [
                "Increase aripiprazole to 15 mg once daily",
                "Enroll in the coordinated specialty care program: care coordinator, therapist, peer specialist, and help returning to work",
                "MRI and EEG results at the next visit",
                "Call the team at once for restlessness after the increase"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder",
              "assessment": "Still drinking two or three glasses most evenings. AST 58, ALT 44 and GGT 96 U/L with MCV 102 fL and PEth 284 ng/mL at intake, consistent with heavy drinking; the liver tests are well below three times the upper limit, and he takes no opioids, so naltrexone is suitable",
              "plan": [
                "Start naltrexone 50 mg once daily",
                "Continue thiamine",
                "Liver tests and PEth at the six-week visit",
                "Carry a card saying he takes naltrexone"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Antipsychotic dose, adherence, and response",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Aripiprazole 10 mg for four weeks with full adherence; partial response; increased to 15 mg",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Psychotic and mood symptoms, and early warning signs",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Name called at sleep onset on some nights; brief night-time suspiciousness; none by day",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Akathisia, parkinsonism, and sedation",
              "cadence": "Every visit in the first months and after any dose change",
              "status": "completed_today",
              "detail": "No akathisia, parkinsonism, or sedation",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Abnormal Involuntary Movement Scale (AIMS)",
              "cadence": "Baseline, then every 6 months",
              "status": "completed_today",
              "detail": "Baseline AIMS score 0, done with the consultation; repeat at six months",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit for 6 months after starting, then quarterly (CMID: baseline, 4, 8, and 12 weeks, then quarterly)",
              "status": "completed_today",
              "detail": "64.5 kg at four weeks, from 64.0 at intake",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Waist circumference",
              "cadence": "Baseline, then yearly",
              "status": "completed_today",
              "detail": "86 cm. This baseline was due at intake and was taken today instead; nothing was lost because weight was measured at intake. Waist is now part of the visit template",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Baseline, 12 weeks, then yearly",
              "status": "up_to_date",
              "detail": "128/80 at intake; 124/78 today",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting glucose and A1c",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "up_to_date",
              "detail": "Fasting glucose 91 mg/dL and A1c 5.3% at intake; next at 12 weeks",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting lipid panel",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "up_to_date",
              "detail": "Total cholesterol 184, LDL 106, HDL 52, triglycerides 130 mg/dL at intake; next at 12 weeks",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Prolactin",
              "cadence": "If symptoms of high prolactin",
              "status": "not_indicated",
              "detail": "Aripiprazole rarely raises prolactin; no symptoms",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Electrocardiogram",
              "cadence": "Before starting if there are cardiac risk factors or QT-prolonging drugs",
              "status": "not_indicated",
              "detail": "No cardiac history, fainting, or QT-prolonging drugs; aripiprazole has little effect on the QT interval",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "First-episode workup (MRI and EEG)",
              "cadence": "Once, in the first-episode workup",
              "status": "completed_today",
              "detail": "Brain MRI and sleep-deprived EEG done this morning; results pending",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression measure (PHQ-9)",
              "cadence": "Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically",
              "status": "completed_today",
              "detail": "PHQ-9 11, from 13; item 9 scored 1",
              "observation_ids": [
                "OBS-PHQ9-V2"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Passive thoughts of not waking up less often, no intent or plan; safety plan reviewed; no firearm access; medicines two weeks at a time; the 988 Suicide & Crisis Lifeline in his phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sleep",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "About six hours, broken; regular times and less evening coffee agreed",
              "guideline_ids": [
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking (AUDIT-C and PEth)",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "up_to_date",
              "detail": "AUDIT-C 9 and PEth 284 ng/mL at intake; two or three glasses most evenings now",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone: liver tests and opioid exposure",
              "cadence": "Liver tests before starting, then at 1 to 3 months and every 6 to 12 months",
              "status": "completed_today",
              "detail": "AST 58, ALT 44 U/L at intake, well below three times the upper limit; urine drug test negative for opioids; naltrexone started",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Taking thiamine 100 mg daily since the hospital",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Psychiatry consultation",
              "cadence": "At the start of treatment for a first episode",
              "status": "completed_today",
              "detail": "Seen by Dr. Feld today",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-NIMH-CSC"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Coordinated specialty care engagement",
              "cadence": "Ongoing, for up to two to three years",
              "status": "completed_today",
              "detail": "Enrolled today; first meetings with the care coordinator and therapist booked",
              "guideline_ids": [
                "GL-NIMH-CSC"
              ]
            }
          ],
          "follow_up": "Six-week visit in four weeks with liver tests, PEth, the PHQ-9, and the MRI and EEG results. Care coordinator by phone weekly. Call at once for restlessness, voices by day, or dark thoughts",
          "guideline_ids": [
            "GL-APA-SCZ-2020",
            "GL-ADA-APA-2004",
            "GL-NIMH-CSC",
            "GL-SUD-2021",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CANMAT-BD-2018"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Six-week review: symptoms, side effects, alcohol, sleep, and test results",
        "status": "finished",
        "date": "2026-03-02",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Six-week review: symptoms, side effects, alcohol, sleep, and test results",
          "hpi": {
            "narrative": "Mr. van Gogh returns six weeks after his first visit and two weeks after the sick visit for akathisia, when aripiprazole went back to 10 mg and propranolol was started. The restlessness eased within three days and has been gone for more than a week. The night-time voices have not returned on 10 mg. He sleeps six and a half to seven hours. He is painting again for a few hours most days, which he says matters more to him than anything. He takes naltrexone daily and now has one or two glasses of wine on most evenings; he notices that he wants a second glass less. His mood is better, and the thoughts of not waking up have stopped. He meets the care coordinator weekly and has seen the therapist twice.",
            "elements": [
              {
                "label": "Aripiprazole",
                "value": "10 mg daily for two weeks, every dose taken"
              },
              {
                "label": "Akathisia",
                "value": "Resolved within three days; propranolol 10 mg twice daily"
              },
              {
                "label": "Psychotic symptoms",
                "value": "None"
              },
              {
                "label": "Sleep",
                "value": "Six and a half to seven hours"
              },
              {
                "label": "Alcohol",
                "value": "One or two glasses of wine most evenings"
              },
              {
                "label": "Mood",
                "value": "Better; PHQ-9 8; item 9 scored 0"
              }
            ]
          },
          "ros": [
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No restlessness, stiffness, tremor, seizures, or lost time"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No dizziness or fainting on propranolol"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Mild nausea in the first days of naltrexone, now gone"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "No voices or suspiciousness; mood improving; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 64.9 kg; blood pressure 120/76, pulse 76"
            },
            {
              "system": "Neurological",
              "finding": "No akathisia (Barnes global rating 0), rigidity, tremor, or abnormal movements"
            },
            {
              "system": "Psychiatric",
              "finding": "Brighter affect; organized; no psychotic features; insight good"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "First episode of psychosis with mood features, provisional diagnosis",
              "assessment": "Remission of psychotic symptoms on aripiprazole 10 mg. The brain MRI was normal, and the sleep-deprived EEG showed no epileptiform discharges; a normal EEG does not exclude focal epilepsy, but with no seizure-like events the team will not test further unless such events occur. Safety reviewed: no thoughts of suicide or self-harm; the safety plan is current",
              "plan": [
                "Continue aripiprazole 10 mg daily",
                "Report any episodes of lost time, odd smells or tastes, or sudden fear, which would reopen the question of seizures"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Akathisia",
              "assessment": "Resolved on the lower dose",
              "plan": [
                "Stop propranolol today"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on naltrexone",
              "assessment": "PEth down from 284 to 122 ng/mL; AST 41, ALT 37 and GGT 68 U/L, improving on naltrexone",
              "plan": [
                "Continue naltrexone and thiamine",
                "His own goal: no more than one glass of wine with dinner, and none on two days a week"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Antipsychotic dose, adherence, and response",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Aripiprazole 10 mg since the sick visit; full adherence; remission of psychotic symptoms",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Psychotic and mood symptoms, and early warning signs",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No hallucinations or suspiciousness; no early warning signs",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Akathisia, parkinsonism, and sedation",
              "cadence": "Every visit in the first months and after any dose change",
              "status": "completed_today",
              "detail": "Akathisia resolved; no parkinsonism or sedation; propranolol stopped",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit for 6 months after starting, then quarterly (CMID: baseline, 4, 8, and 12 weeks, then quarterly)",
              "status": "completed_today",
              "detail": "64.9 kg at eight weeks, from 64.0",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Baseline, 12 weeks, then yearly",
              "status": "completed_today",
              "detail": "120/76",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting glucose and A1c",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "up_to_date",
              "detail": "Next at the three-month visit",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting lipid panel",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "up_to_date",
              "detail": "Next at the three-month visit",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "First-episode workup (MRI and EEG)",
              "cadence": "Once, in the first-episode workup",
              "status": "completed_today",
              "detail": "Brain MRI normal; sleep-deprived EEG without epileptiform discharges",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression measure (PHQ-9)",
              "cadence": "Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically",
              "status": "completed_today",
              "detail": "PHQ-9 8, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; safety plan current; the 988 Suicide & Crisis Lifeline in his phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sleep",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Six and a half to seven hours at regular times",
              "guideline_ids": [
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking (AUDIT-C and PEth)",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "completed_today",
              "detail": "PEth 122 ng/mL, from 284",
              "observation_ids": [
                "OBS-PETH-V3"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone: liver tests and opioid exposure",
              "cadence": "Liver tests before starting, then at 1 to 3 months and every 6 to 12 months",
              "status": "completed_today",
              "detail": "AST 41, ALT 37, GGT 68 U/L, improving; no opioid use",
              "observation_ids": [
                "OBS-AST-V3",
                "OBS-ALT-V3",
                "OBS-GGT-V3"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Taking thiamine daily",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Coordinated specialty care engagement",
              "cadence": "Ongoing, for up to two to three years",
              "status": "completed_today",
              "detail": "Care coordinator weekly; therapist twice; peer specialist introduced",
              "guideline_ids": [
                "GL-NIMH-CSC"
              ]
            }
          ],
          "follow_up": "Three-month visit with fasting glucose, A1c, lipids, liver tests, PEth, and the PHQ-9. Care coordinator weekly; therapist every two weeks",
          "guideline_ids": [
            "GL-APA-SCZ-2020",
            "GL-ADA-APA-2004",
            "GL-NIMH-CSC",
            "GL-SUD-2021",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CANMAT-BD-2018"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Three-month review with the 12-week metabolic check",
        "status": "finished",
        "date": "2026-04-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Three-month review with the 12-week metabolic check",
          "hpi": {
            "narrative": "Mr. van Gogh returns three months after his first visit, fifteen weeks after aripiprazole was started in hospital, fasting for his blood tests. He has had no voices, suspiciousness, or confusion since the six-week visit. He takes aripiprazole 10 mg and naltrexone every morning. He sleeps about seven hours and goes to bed by midnight; he noticed once that after a late night of work he felt a rush of ideas the next day, and he went to bed early as his plan says. He paints most days, outdoors now that spring has come, and has sold two paintings. He drinks one glass of wine with dinner on most days and none on two days a week. His appetite is a little greater than before. His mood is steady; he has not had thoughts of suicide or self-harm.",
            "elements": [
              {
                "label": "Psychotic symptoms",
                "value": "None since the six-week visit"
              },
              {
                "label": "Early warning signs",
                "value": "One day of racing ideas after a late night; managed with sleep"
              },
              {
                "label": "Sleep",
                "value": "About seven hours at regular times"
              },
              {
                "label": "Alcohol",
                "value": "One glass of wine with dinner on most days; two alcohol-free days a week"
              },
              {
                "label": "Mood",
                "value": "Steady; PHQ-9 6; item 9 scored 0"
              },
              {
                "label": "Weight",
                "value": "Appetite slightly greater; weight up 1.7 kg since intake"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Appetite a little greater; weight up 1.7 kg"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No thirst or frequent urination"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No restlessness, stiffness, tremor, or seizures"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "No voices or suspiciousness; mood steady; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 65.7 kg, BMI 22.7; waist 87 cm; blood pressure 122/78, pulse 74"
            },
            {
              "system": "Neurological",
              "finding": "No akathisia, rigidity, tremor, or abnormal movements"
            },
            {
              "system": "Psychiatric",
              "finding": "Euthymic; organized; no psychotic features; speech normal in rate"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "First episode of psychosis with mood features, provisional diagnosis, in remission",
              "assessment": "Remission for about two months. The day of racing ideas after a late night was an early warning sign that he managed well; it did not progress. The 12-week metabolic check is normal: fasting glucose 94 mg/dL, A1c 5.4%, total cholesterol 191, LDL 112, HDL 50 and triglycerides 142 mg/dL; weight up 2.7%, below the 5% that would call for action. Antipsychotic treatment continues after a first episode; the length of treatment will be decided with him later in the year. Safety reviewed: no thoughts of suicide or self-harm; the safety plan is current",
              "plan": [
                "Continue aripiprazole 10 mg daily",
                "Keep to the sleep plan and call the team after two short nights or more racing ideas",
                "Yearly glucose, A1c and lipids from now"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on naltrexone",
              "assessment": "PEth down to 46 ng/mL; AST 33, ALT 31 and GGT 49 U/L, now normal",
              "plan": [
                "Continue naltrexone and thiamine",
                "Liver tests and PEth at six months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Antipsychotic dose, adherence, and response",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Aripiprazole 10 mg; full adherence; in remission",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Psychotic and mood symptoms, and early warning signs",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No psychotic symptoms; one day of racing ideas after a late night, managed with sleep",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Akathisia, parkinsonism, and sedation",
              "cadence": "Every visit in the first months and after any dose change",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit for 6 months after starting, then quarterly (CMID: baseline, 4, 8, and 12 weeks, then quarterly)",
              "status": "completed_today",
              "detail": "65.7 kg (BMI 22.7), up 2.7% from intake. Taken at 15 weeks rather than the CMID's 12, within the APA's four months",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Waist circumference",
              "cadence": "Baseline, then yearly",
              "status": "completed_today",
              "detail": "87 cm",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Baseline, 12 weeks, then yearly",
              "status": "completed_today",
              "detail": "122/78",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting glucose and A1c",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "completed_today",
              "detail": "Fasting glucose 94 mg/dL; A1c 5.4%; yearly from now",
              "observation_ids": [
                "OBS-FGLU-V4",
                "OBS-A1C-V4"
              ],
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting lipid panel",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "completed_today",
              "detail": "Total cholesterol 191, LDL 112, HDL 50, triglycerides 142 mg/dL; yearly from now",
              "observation_ids": [
                "OBS-CHOL-V4",
                "OBS-LDL-V4",
                "OBS-HDL-V4",
                "OBS-TG-V4"
              ],
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression measure (PHQ-9)",
              "cadence": "Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically",
              "status": "deferred",
              "detail": "PHQ-9 6 today, item 9 scored 0. No PHQ-9 was taken in the seven weeks since the six-week visit, longer than the monthly measure advised during acute treatment, because no visit fell in that time. No harm resulted: the score fell from 8 to 6 and the care coordinator saw him weekly. Corrective action: the care coordinator now gives the PHQ-9 monthly between visits",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; safety plan reviewed; no firearm access",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sleep",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "About seven hours; in bed by midnight",
              "guideline_ids": [
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking (AUDIT-C and PEth)",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "completed_today",
              "detail": "PEth 46 ng/mL",
              "observation_ids": [
                "OBS-PETH-V4"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone: liver tests and opioid exposure",
              "cadence": "Liver tests before starting, then at 1 to 3 months and every 6 to 12 months",
              "status": "completed_today",
              "detail": "AST 33, ALT 31, GGT 49 U/L, normal",
              "observation_ids": [
                "OBS-AST-V4",
                "OBS-ALT-V4",
                "OBS-GGT-V4"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Taking thiamine daily",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Coordinated specialty care engagement",
              "cadence": "Ongoing, for up to two to three years",
              "status": "completed_today",
              "detail": "Therapist every two weeks; peer specialist monthly; supported work plan: selling his paintings again",
              "guideline_ids": [
                "GL-NIMH-CSC"
              ]
            }
          ],
          "follow_up": "Preventive visit in eight weeks. Six-month review with the AIMS, PEth, liver tests, and blood count. Care coordinator monthly, with the PHQ-9",
          "guideline_ids": [
            "GL-APA-SCZ-2020",
            "GL-ADA-APA-2004",
            "GL-NIMH-CSC",
            "GL-SUD-2021",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CANMAT-BD-2018"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six-month review: diagnosis, relapse prevention, movement check, and alcohol",
        "status": "finished",
        "date": "2026-07-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Six-month review: diagnosis, relapse prevention, movement check, and alcohol",
          "hpi": {
            "narrative": "Mr. van Gogh returns six months after his first visit. He has had no psychotic symptoms for more than four months and no racing ideas since the spring. He takes aripiprazole 10 mg and naltrexone daily. He sleeps seven hours. He is painting every day and preparing work for a small exhibition. He drinks a glass of wine with dinner on some days and none on others. His mood is good. The care coordinator's monthly PHQ-9 calls have been in the low range. He has had no thoughts of suicide or self-harm. His hepatitis C antibody from the preventive visit was nonreactive.",
            "elements": [
              {
                "label": "Psychotic symptoms",
                "value": "None for more than four months"
              },
              {
                "label": "Mood",
                "value": "Good; PHQ-9 3"
              },
              {
                "label": "Sleep",
                "value": "Seven hours at regular times"
              },
              {
                "label": "Alcohol",
                "value": "A glass of wine with dinner on some days"
              },
              {
                "label": "Hepatitis C antibody",
                "value": "Nonreactive"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight stable"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No restlessness, stiffness, tremor, abnormal movements, or seizures"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "No voices, suspiciousness, or racing ideas; mood good; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 65.4 kg; blood pressure 118/76, pulse 70"
            },
            {
              "system": "Neurological",
              "finding": "AIMS score 0: no abnormal movements of the face, lips, jaw, tongue, limbs, or trunk; no akathisia or rigidity"
            },
            {
              "system": "Psychiatric",
              "finding": "Euthymic and engaged; organized; no psychotic features"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "First episode of psychosis with mood features, provisional diagnosis, in remission",
              "assessment": "Full remission for more than four months, with no symptoms between, a normal MRI and EEG, and no seizure-like events. This course makes schizophrenia unlikely and leaves bipolar I disorder with psychotic features and a psychosis related to heavy drinking and its sudden withdrawal as the leading possibilities. The diagnosis stays provisional: a manic or depressive episode would point to bipolar disorder, and psychosis without mood change or alcohol would point to a schizophrenia-spectrum disorder. A mood stabilizer would be considered if a mood episode occurs. AIMS score 0. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and psychiatric advance directive are current",
              "plan": [
                "Continue aripiprazole 10 mg daily",
                "Decide with him and Dr. Feld near the one-year mark whether and how slowly to reduce it, with a written relapse plan",
                "AIMS again in six months; glucose, A1c and lipids yearly"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on naltrexone",
              "assessment": "PEth 16 ng/mL, from 284 at intake: light drinking, as he chose. AST 27, ALT 26 and GGT 36 U/L normal; MCV back to 95 fL",
              "plan": [
                "Continue naltrexone for at least six more months, then review",
                "Stop thiamine now that drinking is light and meals are regular"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Antipsychotic dose, adherence, and response",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Aripiprazole 10 mg; full adherence; full remission",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Psychotic and mood symptoms, and early warning signs",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No psychotic or mood symptoms; no early warning signs",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Akathisia, parkinsonism, and sedation",
              "cadence": "Every visit in the first months and after any dose change",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Abnormal Involuntary Movement Scale (AIMS)",
              "cadence": "Baseline, then every 6 months",
              "status": "completed_today",
              "detail": "AIMS score 0 at six months; repeat in six months",
              "guideline_ids": [
                "GL-APA-SCZ-2020",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit for 6 months after starting, then quarterly (CMID: baseline, 4, 8, and 12 weeks, then quarterly)",
              "status": "completed_today",
              "detail": "65.4 kg, up 2.2% from intake; quarterly from now",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure",
              "cadence": "Baseline, 12 weeks, then yearly",
              "status": "completed_today",
              "detail": "118/76",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting glucose and A1c",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "up_to_date",
              "detail": "Normal at the three-month visit; next in a year",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Fasting lipid panel",
              "cadence": "Baseline, 12 weeks to 4 months, then yearly",
              "status": "up_to_date",
              "detail": "Normal at the three-month visit; next in a year",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-CMID-2026",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression measure (PHQ-9)",
              "cadence": "Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically",
              "status": "completed_today",
              "detail": "PHQ-9 3, from 13 at intake: remission",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood Disorder Questionnaire",
              "cadence": "When a new depressive episode is evaluated",
              "status": "not_indicated",
              "detail": "No depressive episode now; the possibility of bipolar disorder is followed through the mood history at each visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No thoughts of suicide or self-harm; safety plan and psychiatric advance directive current; the 988 Suicide & Crisis Lifeline in his phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sleep",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Seven hours at regular times",
              "guideline_ids": [
                "GL-CANMAT-BD-2018",
                "GL-CANMAT-BD-2023",
                "GL-APA-SCZ-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Drinking (AUDIT-C and PEth)",
              "cadence": "PEth at intake and at each check while drinking continues; AUDIT-C yearly",
              "status": "completed_today",
              "detail": "PEth 16 ng/mL; AUDIT-C 3 at the preventive visit",
              "observation_ids": [
                "OBS-PETH-V5"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naltrexone: liver tests and opioid exposure",
              "cadence": "Liver tests before starting, then at 1 to 3 months and every 6 to 12 months",
              "status": "completed_today",
              "detail": "AST 27, ALT 26, GGT 36 U/L, normal",
              "observation_ids": [
                "OBS-AST-V5",
                "OBS-ALT-V5",
                "OBS-GGT-V5"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count",
              "cadence": "At intake and with liver tests while drinking",
              "status": "completed_today",
              "detail": "White cells 6.4, hemoglobin 14.6 g/dL, MCV 95 fL (from 102), platelets 214",
              "observation_ids": [
                "OBS-WBC-V5",
                "OBS-HGB-V5",
                "OBS-MCV-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Thiamine",
              "cadence": "While drinking heavily",
              "status": "completed_today",
              "detail": "Stopped today",
              "guideline_ids": [
                "GL-SUD-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Hepatitis B vaccine",
              "cadence": "Two doses at least four weeks apart",
              "status": "completed_today",
              "detail": "Dose 2 given today; series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Coordinated specialty care engagement",
              "cadence": "Ongoing, for up to two to three years",
              "status": "completed_today",
              "detail": "Therapist every two weeks; peer specialist monthly; exhibition planned",
              "guideline_ids": [
                "GL-NIMH-CSC"
              ]
            }
          ],
          "follow_up": "Visits every three months with weight and the PHQ-9. Psychiatry review with Dr. Feld near the one-year mark about the length of antipsychotic treatment. AIMS in six months; glucose, A1c and lipids in a year. Influenza and COVID-19 vaccines in the autumn",
          "guideline_ids": [
            "GL-APA-SCZ-2020",
            "GL-ADA-APA-2004",
            "GL-NIMH-CSC",
            "GL-SUD-2021",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CANMAT-BD-2018",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for restlessness after an antipsychotic dose increase",
        "status": "finished",
        "date": "2026-02-16",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Restlessness and inability to sit still for five days",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. van Gogh called the coordinated specialty care team and was seen the same day. Two weeks ago his aripiprazole was increased from 10 to 15 mg because he still heard his name called as he fell asleep. Since then the night-time voices have stopped, but for five days he has felt an inner restlessness he cannot switch off. He cannot sit at his easel for more than a few minutes, paces his studio, shifts his legs when sitting, and lies awake because his legs will not keep still. The feeling is worst in the late afternoon, a few hours after his morning dose. He was frightened that the illness was coming back, and the restlessness makes him irritable and miserable. He has had no confusion, no voices by day, and no stiffness or tremor. He has taken naltrexone daily, has had one or two drinks on three evenings this week, and has not drunk more to calm the feeling. He has not had thoughts of suicide or self-harm; the passive thoughts of not waking up have not returned.",
            "elements": [
              {
                "label": "Onset",
                "value": "Five days ago, nine days after the aripiprazole increase to 15 mg"
              },
              {
                "label": "Location",
                "value": "Inner restlessness, mainly in the legs"
              },
              {
                "label": "Duration",
                "value": "Five days, constant"
              },
              {
                "label": "Character",
                "value": "An urge to move that he cannot resist; pacing; shifting his legs while sitting"
              },
              {
                "label": "Severity",
                "value": "Moderate; cannot paint or sleep through it"
              },
              {
                "label": "Timing",
                "value": "Worst in the late afternoon"
              },
              {
                "label": "Context",
                "value": "Aripiprazole increased from 10 to 15 mg two weeks ago"
              },
              {
                "label": "Modifying factors",
                "value": "Walking eases it briefly; coffee makes it worse"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Poor sleep and irritability; no voices by day, confusion, stiffness, tremor, fever, or thoughts of suicide or self-harm"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or sweats"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Restless legs and an urge to move; no stiffness, tremor, abnormal movements of the face or tongue, or weakness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations, fainting, or chest pain"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No wheeze or asthma"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Anxious and irritable with the restlessness; poor sleep; no voices by day; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Restless; stands and walks twice during the visit; blood pressure 130/82, pulse 96"
            },
            {
              "system": "Neurological",
              "finding": "Shifts his weight and crosses and uncrosses his legs while seated; Barnes global akathisia rating 3 (moderate); no rigidity, cogwheeling, tremor, or abnormal facial or tongue movements; gait normal"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear; no wheeze"
            },
            {
              "system": "Psychiatric",
              "finding": "Distressed by the restlessness but organized and engaged; no hallucinations or delusions elicited"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Akathisia from aripiprazole",
              "assessment": "Moderate akathisia after the dose increase: subjective restlessness with observed movement, without parkinsonism or dyskinesia. It is not a return of the psychosis. Akathisia is distressing and is linked with impulsive behavior and suicidal thoughts, so it is treated promptly. Asthma and a slow pulse, which would prevent propranolol, are absent. A benzodiazepine is avoided because of his alcohol use",
              "plan": [
                "Return aripiprazole to 10 mg daily from tomorrow",
                "Propranolol 10 mg twice daily for a few weeks",
                "Cut coffee to one cup in the morning",
                "Phone check from the care coordinator in three days"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "First episode of psychosis, provisional diagnosis",
              "assessment": "No voices since the increase; the lower dose may let them return, so he and the team will watch for them. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in his phone, and he knows akathisia can make him feel desperate and to call if it does",
              "plan": [
                "If night-time voices return on 10 mg, the team will review the dose at the six-week visit rather than raise it now",
                "Six-week visit as planned"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on naltrexone",
              "assessment": "One or two drinks on three evenings this week; he has not used alcohol to calm the restlessness",
              "plan": [
                "Continue naltrexone and thiamine",
                "No alcohol to treat the restlessness or to get to sleep"
              ]
            }
          ],
          "follow_up": "Care coordinator phone check in three days. Six-week visit in two weeks, or sooner if the restlessness does not ease within a week or if voices or dark thoughts return",
          "guideline_ids": [
            "GL-APA-SCZ-2020",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the side effect is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-06-15",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on a tablet in the waiting room and reviewed with him by Dr. Verhoeven",
          "hpi": {
            "narrative": "Mr. van Gogh is a 36-year-old painter with a first episode of psychosis five months ago, on aripiprazole 10 mg daily, and an alcohol use disorder on naltrexone, who comes for his yearly preventive visit eight weeks after his three-month review. He has had no voices, confusion, or suspiciousness since the six-week visit. He sleeps about seven hours and is painting most days, outdoors in the fields when the weather is good. He drinks one or two glasses of wine with dinner on some days and no spirits. He meets his therapist from the coordinated specialty care team every two weeks and the peer specialist monthly. He smokes his pipe each day. His mood is good and his PHQ-9 today is 4. He has no new concerns.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 36"
              },
              {
                "label": "Psychosis",
                "value": "No symptoms for more than three months on aripiprazole 10 mg"
              },
              {
                "label": "Alcohol",
                "value": "One or two glasses of wine on some days; AUDIT-C 3"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 4; item 9 scored 0"
              },
              {
                "label": "Medicines",
                "value": "Aripiprazole 10 mg daily; naltrexone 50 mg daily; thiamine 100 mg daily"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and much better than in the winter"
            },
            {
              "domain": "Psychosocial",
              "finding": "Supported by a friend nearby and the coordinated specialty care team; selling some work again"
            },
            {
              "domain": "Substance use",
              "finding": "AUDIT-C 3; no spirits since the spring; no drug use"
            },
            {
              "domain": "Tobacco",
              "finding": "Smokes a pipe daily"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks several kilometres most days to paint outdoors"
            },
            {
              "domain": "Nutrition",
              "finding": "Eats two regular meals a day now, with fewer meals of only bread and coffee"
            },
            {
              "domain": "Sleep",
              "finding": "About seven hours on most nights, at regular times"
            },
            {
              "domain": "Sun and heat",
              "finding": "Paints in full sun for hours; rarely wears a hat or sunscreen"
            },
            {
              "domain": "Work safety",
              "finding": "Uses oil paints and solvents in his studio; cleans brushes with turpentine, with the window open"
            },
            {
              "domain": "Sexual health",
              "finding": "Not in a relationship; uses condoms with new partners"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe; no firearm in the home"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats, or weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision or color perception"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Hearing normal on both sides; the healed left ear causes no pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, nausea from naltrexone, or change in bowels"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms; no sexual side effects"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No changing moles; sunburn on the neck at times"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No restlessness, stiffness, tremor, or abnormal movements; no seizures or episodes of confusion"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 score 4; no voices or suspiciousness; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 65.8 kg, BMI 22.8; blood pressure 120/78"
            },
            {
              "system": "Head and ears",
              "finding": "Healed scar of the left ear; ear canal and drum normal; hearing normal to whispered voice on both sides"
            },
            {
              "system": "Mouth",
              "finding": "Teeth in fair repair; no lesions"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; liver not enlarged"
            },
            {
              "system": "Skin",
              "finding": "Sun damage on the neck and forearms; no suspicious pigmented lesions"
            },
            {
              "system": "Neurological",
              "finding": "No tremor, rigidity, or abnormal movements; gait normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm, warm, and engaged; thought process organized; no psychotic features"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Pneumococcal and hepatitis B vaccination started today; sun protection and studio ventilation advised",
              "plan": [
                "Hat and sunscreen when painting outdoors; paint in the shade at midday",
                "Clean brushes in a well-ventilated space and keep solvents capped",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "First episode of psychosis, provisional diagnosis, in remission on aripiprazole",
              "assessment": "No psychotic symptoms for more than three months. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in his phone, and he has no firearm. He chose to write a psychiatric advance directive today",
              "plan": [
                "Continue aripiprazole 10 mg daily",
                "Six-month review in five weeks with the AIMS"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alcohol use disorder on naltrexone",
              "assessment": "Drinking much reduced; AUDIT-C 3",
              "plan": [
                "Continue naltrexone and thiamine; PEth and liver tests at six months"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "120/78 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 score 4, from 13 at intake; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 3, from 9 at intake; in treatment",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco cessation",
              "status": "declined",
              "detail": "Smokes a pipe daily; counseling and nicotine replacement offered; he is not ready and will say when he is",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Nonreactive in the first-episode workup at intake",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "completed_today",
              "detail": "Hepatitis C antibody drawn today; once for adults 18 to 79",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "up_to_date",
              "detail": "Not overweight, so screening is not due by age; fasting glucose 94 mg/dL and A1c 5.4% at the 12-week antipsychotic check; next yearly on aripiprazole",
              "guideline_ids": [
                "GL-USPSTF-DM-2021",
                "GL-ADA-APA-2004"
              ]
            },
            {
              "service": "Lipid screening",
              "status": "up_to_date",
              "detail": "Normal at the 12-week antipsychotic check; yearly on aripiprazole; statin assessment begins at 40",
              "guideline_ids": [
                "GL-ADA-APA-2004",
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Begins at 45",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20, recommended for adults with alcohol use disorder",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "No record of vaccination; dose 1 of 2 today, dose 2 at the six-month visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap given in the emergency department with the ear wound care",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza and COVID-19 vaccines, this season",
              "status": "due",
              "detail": "In the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "No dental visit for more than a year; advised to book one",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He chose to complete a psychiatric advance directive: if another episode begins, he wants to be told plainly what is happening, to be treated close to home if he needs admission, to have aripiprazole rather than a medicine that made him restless, and to have his paints brought to him. He named a health care agent, recorded in the confidential part of the chart and not named here. He chose not to record other treatment preferences today. The directive will be revisited yearly or after any episode.",
          "follow_up": "Six-month review in five weeks with the AIMS, PEth, liver tests, blood count, and the second hepatitis B dose. Hepatitis C result by phone. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-01-19",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 64.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 88,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-02-02",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 64.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-03-02",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 64.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-04-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 65.7,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-07-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 65.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-02-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 64.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 130,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 96,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit: faster pulse with restlessness.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-06-15",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 170,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 65.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 22.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Painter; works long days in his own studio and sells some work; lives alone in a rented house that is also his studio. A fellow painter who had been sharing the house left after a heated argument just before the episode",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern work and home history anchored to his documented life in Arles; no real person is named.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Alcohol: before the episode, five or six drinks most days, wine with meals and anise spirits in the evening (AUDIT-C 9). Was treated for alcohol withdrawal in hospital; since discharge two or three drinks most evenings",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic modern alcohol history anchored to his documented drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Tobacco: smokes a pipe daily; not ready to stop now",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic tobacco history; no tobacco diagnosis is coded.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Sleep: for several weeks before the episode he slept three or four hours a night while painting, without feeling tired; since discharge about six hours with broken sleep",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sleep history; reduced need for sleep is one of the mood features in the differential.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Meals irregular when he is working, often bread and coffee; drinks several cups of coffee a day",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition history.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Supports: a friend he paints with who lives nearby, and the coordinated specialty care team; his work is his strongest reason to get well. He decides who is told about his health",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic strengths and supports; no real relative is named or given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities; not yet painting since discharge because he cannot concentrate for long; manages his money and medicines",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert and oriented; quiet and cooperative; speech normal in rate; no current hallucinations by report, though he sometimes hears his name called as he falls asleep; mild suspiciousness at night; thought process organized; insight growing",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood low and flat, ashamed of the episode, which he cannot remember well; PHQ-9 score 13 with item 9 scored 1 for passive thoughts that it would be easier not to wake up; no intent, plan or preparation; no thoughts of harming others",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-01-19",
      "current_ideation": "present",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "His painting and his wish to work again",
        "A friend nearby who knows what happened and checks in on him",
        "Engagement in care and with the coordinated specialty care team",
        "No firearm in his home and no access to one",
        "He asked for help with his mood and his drinking himself"
      ],
      "disposition": "Outpatient care with close follow-up. He has passive thoughts that it would be easier not to wake up, without intent, plan or preparation; the self-injury during the episode happened in confusion and without suicidal intent. His risk is higher in the months after a first episode of psychosis, while he is depressed, and while he is drinking. A written safety plan was made with him, with his own early warning signs (nights with little sleep, hearing voices, drinking more, pulling away from his friend) and what to do about each. Lethal-means counseling: he has no firearm and no access to one and agreed not to acquire one; medicines are dispensed two weeks at a time; he will keep alcohol out of the house while he is low. The 988 Suicide & Crisis Lifeline was given and saved in his phone, with the clinic number. Safety reviewed at every visit",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0007"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the psychosis and alcohol codes and the positive PHQ-9; the passive death wish is anchored to his own letter and makes no claim about his real mental health.",
        "author": "The Human Record generator",
        "created": "2026-11-04T09:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "First episode of psychosis with mood features in a 35-year-old painter, twelve days after discharge from a first psychiatric admission. He takes aripiprazole 10 mg daily, started in hospital, and drinks heavily. Please review the provisional diagnosis and differential, the medication plan, the treatment of his alcohol use, and the workup for seizures, and enroll him in coordinated specialty care",
        "urgency": "Within two weeks, on the same day as his two-week primary care visit",
        "pertinent_history": "For several weeks before the episode he slept three or four hours a night while painting, without feeling tired, and was full of plans, while drinking five or six drinks most days. Just before the episode a fellow painter who shared his house left after a heated argument. He then became acutely confused, with hallucinations and suspiciousness, and injured his left ear himself without suicidal intent; he remembers little of it. In hospital he was treated for alcohol withdrawal and for the ear wound; the confusion cleared over a few days, but hallucinations and suspiciousness lasted longer, and aripiprazole 10 mg and thiamine were started two days before discharge. Today he has no hallucinations by day but hears his name called as he falls asleep; his mood is low (PHQ-9 13, item 9 scored 1 for passive thoughts of not waking up, without intent or plan); a structured safety assessment and safety plan were completed, he has no firearm access, and the 988 Suicide & Crisis Lifeline is in his phone. AUDIT-C 9; he still has two or three drinks most evenings. No personal history of seizures. Results today: white cells 6.8, hemoglobin 14.2 g/dL, MCV 102 fL, platelets 172; sodium 137, potassium 4.1, creatinine 0.94 mg/dL, eGFR 108; fasting glucose 91 mg/dL, A1c 5.3%; total cholesterol 184, LDL 106, HDL 52, triglycerides 130 mg/dL; AST 58, ALT 44, GGT 96 U/L; TSH 1.8 mIU/L; vitamin B12 388 pg/mL; PEth 284 ng/mL. Urine drug test, HIV and syphilis tests sent. Brain MRI and a sleep-deprived EEG are booked for the morning of your visit. Weight 64.0 kg, blood pressure 128/80. He decides who is told about his health",
        "questions": [
          "What is the most likely diagnosis, and how should the differential be settled over time?",
          "Is aripiprazole 10 mg the right medicine and dose, and should a mood stabilizer be added now?",
          "Does he need more than a brain MRI and a sleep-deprived EEG to look for epilepsy?",
          "Which medicine should he take for his alcohol use, and how should his drinking be managed alongside the psychosis?",
          "How long should the antipsychotic continue, and what monitoring and coordinated specialty care do you advise?"
        ]
      },
      "consultant_note": {
        "history": "Mr. van Gogh, a 35-year-old painter, is seen at the request of Dr. Verhoeven four weeks after aripiprazole 10 mg was started in hospital. He has taken every dose. The confusion of the acute episode has cleared, and he hears nothing by day, but on some nights he hears his name called as he falls asleep and feels briefly that people in the street are talking about him. In the weeks before the episode he slept three or four hours a night, painted almost continuously, and felt full of energy and plans; he was drinking five or six drinks a day, and the confusion began soon after he stopped drinking abruptly. Since discharge his mood has been low and he feels ashamed of what he cannot remember; passive thoughts that it would be easier not to wake up are becoming less frequent, and he has no intent or plan. He drinks two or three glasses of wine most evenings. He has never had a seizure, lost time, or had spells of odd smells or sudden fear. He had his brain MRI and EEG this morning. He wants to understand what happened and to paint again",
        "data_reviewed": "Dr. Verhoeven's intake note, safety assessment, and safety plan. Intake results: MCV 102 fL; AST 58, ALT 44, GGT 96 U/L; PEth 284 ng/mL; creatinine 0.94 mg/dL; fasting glucose 91 mg/dL; A1c 5.3%; total cholesterol 184, LDL 106, HDL 52, triglycerides 130 mg/dL; TSH 1.8 mIU/L; vitamin B12 388 pg/mL; urine drug test negative; HIV and syphilis tests nonreactive. PHQ-9 13 at intake and 11 today; AUDIT-C 9. Weight 64.5 kg today, from 64.0. Brain MRI and EEG done this morning; reports pending",
        "exam": [
          {
            "system": "General",
            "finding": "Well; blood pressure 124/78, pulse 82; waist 86 cm"
          },
          {
            "system": "Neurological",
            "finding": "No akathisia, rigidity, tremor, or abnormal movements; AIMS score 0"
          },
          {
            "system": "Mental status",
            "finding": "Quiet and cooperative; affect constricted but reactive; thought process organized; no hallucinations or delusions elicited; no suicidal intent or plan; insight good"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "First episode of psychosis with mood features, provisional diagnosis",
            "assessment": "The leading possibilities are bipolar I disorder with psychotic features, suggested by weeks of reduced need for sleep and increased activity before the episode and low mood after it, and a psychosis caused by heavy drinking and its abrupt withdrawal, suggested by the timing; the two may have combined. A brief psychotic or schizophreniform disorder remains possible; schizophrenia is less likely with this course. Focal epilepsy is unlikely without seizure-like events but is reasonable to look for once. The diagnosis should stay provisional and be settled by the course: a later manic or depressive episode would point to bipolar disorder, and psychosis without mood change or alcohol to a schizophrenia-spectrum disorder. Aripiprazole is a sound choice for its low metabolic and prolactin effects; the residual night-time symptoms justify a modest increase. A mood stabilizer is not needed now, because aripiprazole also treats mania; lithium would be the first choice if a mood episode occurs"
          },
          {
            "problem_id": "PRB-002",
            "display": "Alcohol use disorder, moderate",
            "assessment": "Drinking is the most changeable risk for relapse and for suicide. He takes no opioids, and his liver tests are well below three times the upper limit, so naltrexone is suitable"
          },
          {
            "problem_id": "PRB-003",
            "display": "Self-injury during confusion",
            "assessment": "The injury happened in confusion and without suicidal intent; his current passive thoughts of not waking up are a separate and treatable part of his low mood. His risk is raised in the months after a first episode, and the safety plan is appropriate"
          }
        ],
        "recommendations": [
          "Increase aripiprazole to 15 mg once daily; if akathisia appears, go back to 10 mg rather than add more medicines, and treat it with propranolol if needed",
          "No mood stabilizer now; consider lithium if a manic or depressive episode occurs",
          "Complete the brain MRI and sleep-deprived EEG; if both are normal and there are no seizure-like events, no further epilepsy testing is needed",
          "Start naltrexone 50 mg daily, continue thiamine, follow drinking with PEth, and treat alcohol and psychosis together in the same team",
          "Enroll him in coordinated specialty care now: care coordination, individual resilience-focused therapy, education for him and the people he chooses, supported return to work, and peer support",
          "Monitor weight at every visit for six months, blood pressure, fasting glucose, A1c and lipids at about 12 weeks and then yearly, akathisia and parkinsonism at each visit early on, and the AIMS every six months",
          "Measure the PHQ-9 at least monthly while he is depressed and review suicide risk at every contact",
          "Treat sleep loss as an early warning sign: regular hours and a plan to call the team after two short nights",
          "Continue the antipsychotic after remission; review the length of treatment with him near the one-year mark, with a written relapse plan before any reduction"
        ],
        "communication": "Discussed with Dr. Verhoeven, who sees him the same day. The plan was explained to Mr. van Gogh, who agreed with it and chose to start the coordinated specialty care program; he decides who else receives this note",
        "follow_up": "Psychiatry review through the coordinated specialty care team as needed, and near the one-year mark about the length of treatment; Dr. Verhoeven continues prescribing and monitoring"
      },
      "guideline_ids": [
        "GL-APA-SCZ-2020",
        "GL-CANMAT-BD-2018",
        "GL-CANMAT-BD-2023",
        "GL-ADA-APA-2004",
        "GL-NIMH-CSC",
        "GL-SUD-2021",
        "GL-SUICIDE-2024"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He wants to understand what happened to him and to stop it happening again, and is frightened that it will",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his documented first crisis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wants to paint every day again and to be able to concentrate",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He is worried about his drinking and his sleep",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "No return of psychotic symptoms and no readmission through six months, on the lowest effective antipsychotic dose",
        "status": "completed",
        "target_date": "2026-07-20",
        "outcome": "No psychotic symptoms since the six-week visit and no admission; aripiprazole 10 mg daily",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic relapse-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "PHQ-9 score below 5 by six months",
        "status": "completed",
        "target_date": "2026-07-20",
        "outcome": "PHQ-9 3",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Reduce drinking to PEth below 20 ng/mL by six months",
        "status": "completed",
        "target_date": "2026-07-20",
        "outcome": "PEth 16 ng/mL from 284",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol goal set with him.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Weight gain under 5% and normal glucose, A1c and lipids at the 12-week check",
        "status": "completed",
        "target_date": "2026-04-20",
        "outcome": "Weight 65.7 kg from 64.0 (2.7%); fasting glucose 94 mg/dL, A1c 5.4%, lipids normal",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Sleep about seven hours on most nights with regular times by three months",
        "status": "completed",
        "target_date": "2026-04-20",
        "outcome": "Seven hours on most nights, in bed by midnight",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sleep goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Continue the antipsychotic started in hospital at the lowest effective dose, with side-effect checks at each visit (akathisia, stiffness, sedation) and monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose, A1c and lipids at baseline, 12 weeks and yearly, and the AIMS at baseline and every six months",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-SCZ-2020",
          "GL-ADA-APA-2004",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic antipsychotic and monitoring plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Psychiatry consultation with the first-episode psychosis coordinated specialty care team to review the provisional diagnosis and differential, the dose, the alcohol plan, and the workup for epilepsy",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-SCZ-2020",
          "GL-NIMH-CSC"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "First-episode workup: blood count, metabolic panel, liver tests, thyroid test, vitamin B12, HIV and syphilis tests, urine drug test, brain MRI, and a sleep-deprived EEG because of the confusion and the question of seizures",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-SCZ-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic diagnostic workup.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Alcohol care: AUDIT-C, PEth at each check to follow drinking, brief counseling with goals he chooses, thiamine, and a medicine for alcohol use disorder once the liver tests are reviewed",
        "status": "completed",
        "guideline_ids": [
          "GL-SUD-2021",
          "GL-USPSTF-ALC-2018",
          "GL-APA-SCZ-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic alcohol plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Coordinated specialty care: a care coordinator, individual resilience-focused therapy, education about psychosis for him and for the people he chooses, support to return to painting and selling his work, and a peer specialist",
        "status": "completed",
        "guideline_ids": [
          "GL-NIMH-CSC",
          "GL-APA-SCZ-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic coordinated specialty care plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Sleep as treatment and as an early warning sign: regular sleep and wake times, no alcohol to get to sleep, less coffee after noon, and a plan to call the team after two nights of short sleep",
        "status": "completed",
        "guideline_ids": [
          "GL-CANMAT-BD-2018",
          "GL-APA-SCZ-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sleep plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, PHQ-9 at each visit, and safety review at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-SUICIDE-2024",
          "GL-CMID-2026",
          "GL-USPSTF-DEP-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic mood and safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Akathisia: aripiprazole back to 10 mg daily, propranolol 10 mg twice daily for a few weeks, and a check of restlessness and of safety at each visit until it settles",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-SCZ-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic side-effect plan decided at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T09:00:00-05:00"
        },
        "recorded_date": "2026-02-16"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-APA-SCZ-2020",
        "title": "The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition",
        "publisher": "American Psychiatric Association (American Journal of Psychiatry)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32867516/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CANMAT-BD-2018",
        "title": "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder",
        "publisher": "CANMAT and ISBD (Bipolar Disorders)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29536616/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CANMAT-BD-2023",
        "title": "The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence",
        "publisher": "Focus (American Psychiatric Publishing)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38695002/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ADA-APA-2004",
        "title": "Consensus development conference on antipsychotic drugs and obesity and diabetes",
        "publisher": "American Diabetes Association, American Psychiatric Association, AACE, and NAASO (Diabetes Care)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/14747245/",
        "version_or_year": "2004"
      },
      {
        "guideline_id": "GL-NIMH-CSC",
        "title": "Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis",
        "publisher": "National Institute of Mental Health",
        "url": "https://www.nimh.nih.gov/health/topics/schizophrenia/raise",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-SUD-2021",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/sud/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-TOB-2021",
        "title": "Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-DM-2021",
        "title": "Prediabetes and Type 2 Diabetes: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the provisional F29 coding and differential, the aripiprazole dosing and the akathisia management, naltrexone with normal-range liver tests, and the metabolic monitoring schedule."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Four Van Gogh Museum pages, Nolen et al. 2020 (open access), and The Art Newspaper logged. The letters edition could not be read as text and is cited through the museum's quotation. Retrospective diagnoses are graded R with their certainty."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Mental-health, self-harm and alcohol claims are marked sensitive; the ear injury is stated once as documented fact and described in the modern record only as self-injury during confusion; his death is recorded as history without detail; the safety assessment records passive ideation without intent, lethal-means counseling and the 988 Suicide & Crisis Lifeline, and safety is reviewed at every visit."
    }
  }
}
